Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Government Forms Panel to Review Pharmaceutical Marketing Code and Enforcement

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Government Forms Panel to Review Pharmaceutical Marketing Code and Enforcement

Analysed 23 Oct 2026·2 sources analysed·United States·Business
Government Forms Panel to Review Pharmaceutical Marketing Code and EnforcementPreviousNext

The Indian government has formed a three-member committee to review the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) and recommend measures to address unethical marketing in the pharmaceutical sector. Chaired by NITI Aayog member M Srinivas, with members Preeti Sudan and Naresh Trehan, the panel will assess the effectiveness of current oversight, enforcement, and transparency mechanisms. It is tasked with submitting recommendations within two months after consulting stakeholders and experts to improve regulation and compliance.

Sentiment
51%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (51/100). Lens Score 56/100.

Outlets measured: economictimes, businessstandard. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 23 Oct 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (51/100)

Sentiment was consistent across outlets (50–52/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

businessstandard broke this story on 23 Oct, 12:59 pm. Other outlets followed.

23 Oct, 12:59 pm2 sources · 2 h23 Oct, 03:18 pm
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
MP Semiconductor Summit 2026 Highlights Rs 15,800 Crore Investment and Industry Growth
Next →
Ganpati Group to Invest Rs 250 Crore in Lucknow Hotel with Sheraton Partnership
1
businessstandard23 Oct, 12:59 pm
Centre forms 3-member panel to review pharma marketing code, enforcement
  • 2
    economictimes23 Oct, 03:18 pm
    Indian pharma: Unethical practices, marketing rules under lens; new review body set up
  • Who's involved

    Institutions and figures named across source coverage.

    Government
    Department of PharmaceuticalsNiti AayogNITI AayogMinistry of Chemicals and FertilisersMinistry of Health and Family Welfare
    Corporate
    Medanta

    Story context

    Category
    Business
    Location
    United States
    Sources analysed
    2
    Last analysed
    23 Oct 2026
    Key entities
    Ministry of Chemicals and FertilizersPharmaceutical marketingMarketingNaresh TrehanMedantaNITI AayogUnited StatesSudanEthicsIndiaChairpersonAll India Institute of Medical Sciences, New Delhi